SEMHF - Siemens Healthineers AG (SEMHF) Q1 2025 Earnings Call Transcript
2025-02-08 06:10:53 ET
Siemens Healthineers AG (SEMHF)
Q1 2025 Earnings Conference Call
February 06, 2025, 02:30 AM ET
Company Participants
Marc Koebernick - Head, IR
Bernd Montag - CEO
Jochen Schmitz - CFO
Conference Call Participants
Hassan Al-Wakeel - Barclays
Julien Dormois - Jefferies
David Adlington - JPMorgan
Robert Davies - Morgan Stanley
Hugo Solvet - Exane
Oliver Reinberg - Kepler
Lisa Clive - Bernstein
Falko Friedrichs - Deutsche Bank
Sezgi Ozener - HSBC
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Siemens Healthineers Conference Call. As a reminder, this conference is being recorded. Before we begin, I would like to draw your attention to the safe harbor statement on Page 2 of the Siemens Healthineers presentation. This conference call may include forward-looking statements. These statements are based on the company's current expectations and certain assumptions and are, therefore, subject to certain risks and uncertainties.
At this time, I would like to turn the call over to your host today, Mr. Marc Koebernick, Head of Investor Relations. Please go ahead, sir.
Marc Koebernick
Thank you, operator. Good morning, and welcome to our first quarter earnings call. I'd like to thank each of you for joining us today. At 7:00 a.m. this morning, we published our Q1 2025 results. All the related material for today's results release is available on the IR section of the Siemens Healthineers web page. In a moment, we'll hear directly from our CEO, Bernd Montag; and our CFO, Jochen Schmitz, and their presentation. After it, we will have a Q&A session. [Operator Instructions] Additionally, please note that a full transcript and recording of today's call will be made and also made available on our Investor Relations web page shortly after the session ends. Again, thank you for being here.
And now I'll turn it over to Bernd Montag.
Bernd Montag
Thank you, Marc.
Dear analysts and investors, welcome to our Q1 earnings call. Great that you can join us. We have made a successful start into the new fiscal year. In Q1, we grew by nearly 6%, well within our full year guidance range.
Adjusted earnings per share also grew driven by top line growth and margin expansion. In addition, we had a very good order intake quarter again. We achieved an excellent equipment book-to-bill of 1.21, which was driven by equipment book-to-bills above one across all businesses and markets. This broad-based order intake was driven by value partnerships and large deals as well as transactional business.
Our Imaging segment started strongly in the new fiscal year. With 8% revenue growth, the Imaging margin was held back by special items in Q1, but was strong on an underlying basis. Jochen will later provide some additional color on these more temporary effects. Advanced Therapies started in similar vein with good growth and some quarterly volatility in the margin. At Varian, we are proud of how the combination of Varian and Siemens Healthineers continues to bear fruit with very good growth and the margin continuing to expand to above 17% in Q1....
Siemens Healthineers AG (SEMHF) Q1 2025 Earnings Call Transcript